SIERRA ONCOLOGY INC's ticker is SRRA and the CUSIP is 82640U404. A total of 74 filers reported holding SIERRA ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.17 and the average weighting 1.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $626,000 | – | 19,538 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 20,316 | $1,117,000 | 100.00% |
| Vivo Capital, LLC | 3,329,509 | $183,090,000 | 18.38% |
| Paradigm Biocapital Advisors LP | 801,314 | $44,064,000 | 8.79% |
| Chicago Capital Management, LLC | 235,395 | $12,944,000 | 7.34% |
| Frazier Life Sciences Management, L.P. | 870,636 | $47,876,000 | 4.52% |
| Versor Investments LP | 1,579,751 | $86,871,000 | 3.33% |
| Penn Mutual Asset Management | 37,424 | $2,058,000 | 2.77% |
| HARVEST MANAGEMENT LLC | 39,400 | $2,167,000 | 2.50% |
| Kellner Capital, LLC | 65,697 | $3,613,000 | 2.44% |
| JACKSON SQUARE CAPITAL, LLC | 101,000 | $5,554,000 | 2.35% |